Prelude Capital Management, LLC Icad Inc Transaction History

Prelude Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$12.57 - $21.22 $143,260 - $241,844	-11,397 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$8.73 - $14.56 $98,221 - $163,814	-11,251 Reduced 49.68%	11,397 $150,000
Q3 2020 Nov 16, 2020	SELL	$8.56 - $11.6 $290,312 - $393,414	-33,915 Reduced 59.96%	22,648 $200,000
Q2 2020 Aug 14, 2020	BUY	$6.63 - $12.85 $93,144 - $180,529	14,049 Added 33.05%	56,563 $565,000
Q1 2020 May 15, 2020	SELL	$6.94 - $14.42 $96,500 - $200,510	-13,905 Reduced 24.65%	42,514 $312,000
Q4 2019 Feb 14, 2020	SELL	$6.23 - $7.98 $293,395 - $375,810	-47,094 Reduced 45.5%	56,419 $438,000
Q3 2019 Nov 14, 2019	BUY	$5.62 - $7.86 $154,550 - $216,150	27,500 Added 36.18%	103,513 $709,000
Q2 2019 Aug 14, 2019	BUY	$4.53 - $7.0 $271,994 - $420,301	60,043 Added 375.97%	76,013 $484,000
Q1 2019 May 15, 2019	BUY	$3.65 - $6.05 $58,290 - $96,618	15,970 New	15,970 $83,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $42.6M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.